Account Bag 0

PRODUCT PROFILE

Kisspeptin-54

£63.00

Kisspeptin-54 is full-length major circulating human kisspeptin isoform. Researchers examine it in relation to gnrh/lh triggering, oocyte maturation and reproductive-axis physiology.

Why it is distinct

Longer-lived isoform with direct human oocyte-maturation research, unlike the shorter kisspeptin-10.

  • Evidence stageClinical research
  • AvailabilityUnavailable
  • Batch recordPublished after verification
  • DispatchConfirmed at checkout

Out of stock

Ask about availability
SKU: ADINA-END-KISSPEPTIN-54-5MG Category: Tags: , ,

PRODUCT INFORMATION

Clear first. Detailed when needed.

What this material is+

Kisspeptin-54 is full-length major circulating human kisspeptin isoform. Researchers examine it in relation to gnrh/lh triggering, oocyte maturation and reproductive-axis physiology.

Research focus+

Researchers study how it activates reproductive hormones and supports egg-maturation research. It lasts longer than Kisspeptin-10, but remains a specialist clinical-research material.

How the mechanism differs+

Activates KISS1R/GPR54 with a more sustained in-vivo LH response than kisspeptin-10.

Evidence and limitations+

Human IVF and reproductive-endocrinology studies include phase 2 work, but it remains investigational.

Testing and batch documentation+

No live certificate is shown for this staging item. ADINA will only publish a batch document after the product identifier, test method and result have been checked.

RESEARCH PROFILE

Understand the distinction.

Molecular role

Full-length major circulating human kisspeptin isoform

Research focus

Researchers study how it activates reproductive hormones and supports egg-maturation research. It lasts longer than Kisspeptin-10, but remains a specialist clinical-research material.

How it works

Activates KISS1R/GPR54 with a more sustained in-vivo LH response than kisspeptin-10.

Key differentiator

Longer-lived isoform with direct human oocyte-maturation research, unlike the shorter kisspeptin-10.

Evidence context

Human IVF and reproductive-endocrinology studies include phase 2 work, but it remains investigational.

Educational research context only. This information is not dosage, administration or personal-use guidance.